CGEM

Cullinan Therapeutics
$17.43
+$0.33 (+1.93%)Jul 27, 2026
3.7FairMoatMint rating

MoatMint rates Cullinan Therapeutics (CGEM) 3.7 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 2.3 out of 10.

Key metrics

The numbers that frame CGEM today
Market cap
$1.07B
P/E (TTM)
-4.8
EV / FCF
-5.6
ROIC
-63.6%
Div yield
0%
Debt / equity
0.0
52wk Low
$5.68
52wk High
$19.43

CGEM stock rating

How CGEM scores on quality, value, growth, momentum and financial health
3.7out of 10
Fair overallFair business, expensive priceTop 63% of ~5,000 US stocks
QualityFair2.3/10
GrowthNeutral4.1/10
MomentumGreat9.5/10
ValuePoor1.6/10
Financial HealthFair3.5/10

Growth

Revenue and earnings trend for CGEM
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about CGEM
Is Cullinan Therapeutics a good buy?
Hold. Cullinan Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks weak. That could put pressure on the long-term business case. We think Cullinan Therapeutics is selling at a very high price.
What is the market capitalization of CGEM?
Cullinan Therapeutics's market capitalization is $1.07B.
What is the P/E ratio for CGEM stock?
Cullinan Therapeutics's current P/E ratio is -4.8.
What is the 52-week high for CGEM stock?
The 52-week high for Cullinan Therapeutics is $19.43. The current close of $17.43 is 10.3% below that high.
What is the 52-week low for CGEM stock?
The 52-week low for Cullinan Therapeutics is $5.68. The current close of $17.43 is 206.9% above that low.
Does CGEM stock pay dividends?
Cullinan Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CGEM?
Cullinan Therapeutics's Debt / Equity ratio is 0.01.